TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > Our Services > Global End-to-End Outsourcing

Global End-to-End Outsourcing

Confidence Beyond Compliance

Today‘s ever-changing market requires expertise and innovative solutions to overcome the challenges of tomorrow. PharmaLex provides regulatory affairs solutions, combines global reach with local presence for its Global End-to-End Full Outsourcing solutions. PharmaLex has an outstanding successful track record and many years of experiences, to provide a viable End-to-End solution, capable of maintaining your products throughout the life cycle while ensuring the highest quality and compliance globally and locally.

The regulatory maintenance of approved products is essential and critically important for pharma compliance. PharmaLex is able to support Pharma companies to refocus their workload on core strategic competencies, and alleviate the challenges caused by constant demands for pre- and post-approval activities for complete product portfolios. At PharmaLex we live what we preach by taking over full responsibility of your product portfolio either globally or on a country level giving you confidence that your products are in good hands – beyond compliance.

PharmaLex has a long history of managing End-to-End full pharma outsourcing programs encompassing the areas of RX, OTC, food, cosmetic and veterinary products.

With our attractive near-shoring models we are able to offer competitive prices while ensuring high quality and instant support in the same time zone as our clients.

The following services are offered in course of our End-to-End full outsourcing programs:

  • Provision of full portfolio outsourcing from global / head-quarter to local affiliate activities including responsibilities in the area of global labeling, CMC (change control and writing), market expansion, worldwide renewals, line extensions and publishing
  • County-based outsourcing taking complete responsibility of all maintenance activities on a local level (Regulatory and Pharmacovigilance activities)
  • Establishment of clear program governance structures
  • Controlling and performance measurement via budget & KPIs
  • Guiding process consultancy and operative innovations
  • Supporting large globally acting customers with small or large number of established products
  • Handling of activities within PharmaLex own systems

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information

We offer support in the following areas

  • Provision of full portfolio responsibilities including global labeling
  • Establishment of clear program governance structures
  • Controlling and performance measurement via budget & KPIs
  • Guiding process consultancy and operative innovations
  • Supporting large globally acting customers with small or large number of
    established products

Related News

Digitalisation in the Pharmaceutical Industry
Digitalisation in the Pharmaceutical Industry
12th September 2019
Virtual QA and management of outsourced activities
Virtual QA and management of outsourced activities
5th September 2019
Good Distribution Practices of Medicinal Products
Good Distribution Practices of Medicinal Products
12th June 2019

Related Resources

Fact Flyers

  • Portfolio Maintenance Outsourcing

Case Studies

  • Case Processing Services
  • Support with retrieval of ICSR Follow-Up information
  • Global PV Outsourcing
  • Full PV Outsourcing of a Global Generics Pharma Company
  • Outsourcing pharmacovigilance activities to PharmaLex
  • Outsourcing clinical trial safety activities to PharmaLex
  • Portfolio Maintenance Outsourcing Local RA responsibility – EU
  • Full service post-marketing and clinical trial PV activities for mid-sized pharma company
  • Portfolio Maintenance Outsourcing – Global RA responsibility
  • Strategic outsourcing of mature product portfolio
  • Portfolio maintenance outsourcing in highly volatile environment
  • End-2-end portfolio maintenance (outsourcing) program
  • Full PV service outsourcing
  • Local lifecycle Regulatory Affairs management

White Papers

  • Managing mature product portfolios - Key challenges and benefits

Webinars

  • A comprehensive approach to regulatory portfolio management

Related Services

  • Post-approval / Maintenance
  • Program Management
  • SMARTPHLEX

What our clients say

Provided honest feedback and collaborative working solutions to obstacles

South Korea based medium sized company
Manager

I just wanted to relay our sincere thanks to you and the team for two really excellent days training. It was well organized and structured to cover regulatory expectations, GMP principle and routine work challenges of industry. The presenters and moderator were highly skilled in this area to accommodate any queries raised during the training session and were well able to keep the team engaged even in remote/virtual training session. The design of training slides was impressive and the use of technology to make virtual training was remarkable.

Lorraine Henry
Compliance Lead, Qualified Person, Amneal Ireland Limited
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
PharmaLexGLOBALPharmaLex@PharmaLexGLOBAL·
8 Jun

Mark A Lane, PhD latest blog here https://lnkd.in/ejDdywz3 explores Integrated Product Development approaches to accelerate drug development.

To find out more register for our IPD webinar https://lnkd.in/eijUBJM5

#pharmadrugdevelopment
#webinar
#biopharmaceutical

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • I just wanted to let you know that the recent EU Codes webinar was excellent. Rina presented a very complex and grey topic in the most clear and digestible manner – a sign of a true expert. The questions in the Q&A were sometimes a little ambiguous but Rina gave clear and relevant answers that provided real clarity.

    Richard Blackwell
    Medical Team Leader, Multi Tumor Franchise Roche Products Ltd
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    You can unsubscribe at any time at data.protection@pharmalex.com

    If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      Please DO NOT send us event/conference information.
      We will not respond and these will be deleted immediately.






      Select your state:

      Privacy Policy

      .
      If you do not wish to receive any communication from us, you may unsubscribe at any time.

      #AskTheExpert #TogetherBEYONDCOVID19





        Select your state:

        .
        You can unsubscribe at any time at data.protection@pharmalex.com

        If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

        #TogetherBEYONDCOVID19

        We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for